PT1471924E - Idraparinux ( sanorg 34006 ) para tratamento e profilaxia secundaria de eventos tromboembolicos venosos em doentes com trombose venosa profunda - Google Patents

Idraparinux ( sanorg 34006 ) para tratamento e profilaxia secundaria de eventos tromboembolicos venosos em doentes com trombose venosa profunda

Info

Publication number
PT1471924E
PT1471924E PT03702514T PT03702514T PT1471924E PT 1471924 E PT1471924 E PT 1471924E PT 03702514 T PT03702514 T PT 03702514T PT 03702514 T PT03702514 T PT 03702514T PT 1471924 E PT1471924 E PT 1471924E
Authority
PT
Portugal
Prior art keywords
sanorg
idraparinux
patients
treatment
venous
Prior art date
Application number
PT03702514T
Other languages
English (en)
Portuguese (pt)
Inventor
Amsterdam Ronald Maria
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PT1471924E publication Critical patent/PT1471924E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT03702514T 2002-01-29 2003-01-23 Idraparinux ( sanorg 34006 ) para tratamento e profilaxia secundaria de eventos tromboembolicos venosos em doentes com trombose venosa profunda PT1471924E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02075374 2002-01-29

Publications (1)

Publication Number Publication Date
PT1471924E true PT1471924E (pt) 2006-09-29

Family

ID=27635850

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03702514T PT1471924E (pt) 2002-01-29 2003-01-23 Idraparinux ( sanorg 34006 ) para tratamento e profilaxia secundaria de eventos tromboembolicos venosos em doentes com trombose venosa profunda

Country Status (22)

Country Link
US (1) US7709463B2 (enExample)
EP (1) EP1471924B1 (enExample)
JP (1) JP4870907B2 (enExample)
CN (1) CN1622813A (enExample)
AR (1) AR038320A1 (enExample)
AT (1) ATE323497T1 (enExample)
AU (1) AU2003205664B2 (enExample)
BR (1) BR0307196A (enExample)
CA (1) CA2472957C (enExample)
CY (1) CY1107661T1 (enExample)
DE (1) DE60304678T2 (enExample)
DK (1) DK1471924T3 (enExample)
EA (1) EA007204B1 (enExample)
ES (1) ES2262971T3 (enExample)
MX (1) MXPA04007310A (enExample)
NO (1) NO332699B1 (enExample)
PE (1) PE20030855A1 (enExample)
PL (1) PL207144B1 (enExample)
PT (1) PT1471924E (enExample)
SI (1) SI1471924T1 (enExample)
TW (1) TWI281861B (enExample)
WO (1) WO2003063881A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2589770A1 (en) * 2004-12-01 2006-06-08 Osi Pharmaceuticals, Inc. N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library
WO2012166611A2 (en) * 2011-05-27 2012-12-06 Immune Disease Institute, Inc. Methods for treating and preventing neutrophil-derived net toxicity and thrombosis
AU2020310172A1 (en) 2019-07-09 2022-03-03 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type

Also Published As

Publication number Publication date
ES2262971T3 (es) 2006-12-01
EP1471924A1 (en) 2004-11-03
HK1072361A1 (en) 2005-08-26
JP4870907B2 (ja) 2012-02-08
BR0307196A (pt) 2004-11-03
JP2005519919A (ja) 2005-07-07
PL370557A1 (en) 2005-05-30
AR038320A1 (es) 2005-01-12
NO332699B1 (no) 2012-12-10
DK1471924T3 (da) 2006-08-21
WO2003063881A1 (en) 2003-08-07
DE60304678D1 (de) 2006-05-24
US7709463B2 (en) 2010-05-04
CN1622813A (zh) 2005-06-01
DE60304678T2 (de) 2007-04-05
PE20030855A1 (es) 2003-10-11
CY1107661T1 (el) 2013-04-18
PL207144B1 (pl) 2010-11-30
US20050209175A1 (en) 2005-09-22
TWI281861B (en) 2007-06-01
ATE323497T1 (de) 2006-05-15
MXPA04007310A (es) 2004-10-29
AU2003205664B2 (en) 2008-06-05
EA200400817A1 (ru) 2005-02-24
CA2472957C (en) 2011-09-13
CA2472957A1 (en) 2003-08-07
NO20043195L (no) 2004-10-29
EP1471924B1 (en) 2006-04-19
SI1471924T1 (sl) 2006-10-31
TW200302104A (en) 2003-08-01
EA007204B1 (ru) 2006-08-25

Similar Documents

Publication Publication Date Title
BR0208352B1 (pt) produto absorvente que pode ser preso novamente com painés laterais sobrepostos e método de fabricação do mesmo em uma direção de máquina.
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
PL2520654T3 (pl) Inhibitory aktywności proteazy serynowej i ich zastosowanie w sposobach i kompozycjach do leczenia zakażeń bakteryjnych
AU2003256520A8 (en) Nitride-based transistors and methods of fabrication thereof using non-etched contact recesses
WO2004030627A3 (en) Synergistic methods and compositions for treating cancer
DK1604678T3 (da) Anvendelse af botulinumtoksin ved behandlingen af postoperativ smerte
AP2005003212A0 (en) Modified 2' and 3' nucleoside prodrugs for treating flaviviridae infections.
PT1420801E (pt) Utilização de fucanos no tratamento de adesões, artrite e psoríase
DK1429756T3 (da) Behandling af xanthoma med azetidinonderivater som sterolabsorptionsinhibitorer
TWI315986B (en) Compositions and methods for treating or preventing pneumococcal infection
DK1256359T3 (da) Sanitær artikel til at bære i kontakt med huden og indrettet til at tilvejebringe metalterapeutiske virkninger
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
IL161512A0 (en) Low concentration of peroxide for treating or preventing vaginal infections
EP1512405A4 (en) COMPOSITION TO TREAT CHLOASMA AND COMPOSITION TO REDUCE MUTUAL APPEARANCE
EE05534B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks kardiomopaatia raviks ja/v?i ennetamiseks
PL377427A1 (pl) Sposoby i kompozycje do leczenia infekcji wirusem opryszczki z zastosowaniem inhibitorów selektywnych względem cyklooksygenazy-2 lub inhibitorów cyklooksygenazy-2 w połączeniu ze środkami przeciwwirusowymi
AU2001233757A1 (en) Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
SE0004101D0 (sv) New use
DE60335511D1 (de) Strahlteilender oder polarisierender Kubus und Herstellungsverfahren
AU2003274963A8 (en) Mda-7 and free radicals in the treatment of cancer
PL370557A1 (en) Idraparinux(sanorg 34006)for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis
IL151436A0 (en) Compositions and methods for treatment and prophylaxis of infections caused by gram positive bacteria
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
AU2003254129A8 (en) Method and composition for treating and preventing hepatitis b infection and symptoms thereof